Wedbush upgraded shares of Cinemark (NYSE:CNK - Free Report) from a neutral rating to an outperform rating in a report released on Friday, Marketbeat.com reports. They currently have $37.00 price objective on the stock, up from their previous price objective of $32.00. Wedbush also issued estimates for Cinemark's Q3 2025 earnings at $0.55 EPS, FY2025 earnings at $1.34 EPS and Q2 2026 earnings at $0.70 EPS.
CNK has been the topic of several other reports. JPMorgan Chase & Co. boosted their price target on Cinemark from $34.00 to $35.00 and gave the company an "overweight" rating in a research note on Monday, May 5th. Benchmark reiterated a "buy" rating and issued a $35.00 price objective on shares of Cinemark in a research note on Wednesday, July 2nd. B. Riley initiated coverage on Cinemark in a report on Friday, May 16th. They issued a "neutral" rating and a $35.00 target price for the company. Deutsche Bank Aktiengesellschaft initiated coverage on Cinemark in a report on Thursday. They issued a "buy" rating and a $36.00 target price for the company. Finally, Roth Capital dropped their target price on Cinemark from $36.00 to $35.00 and set a "buy" rating for the company in a report on Wednesday, July 9th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and ten have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $34.00.
View Our Latest Analysis on Cinemark
Cinemark Stock Performance
CNK traded up $0.08 on Friday, hitting $29.88. 4,222,234 shares of the stock traded hands, compared to its average volume of 3,238,731. Cinemark has a 52 week low of $20.43 and a 52 week high of $36.28. The company has a current ratio of 0.79, a quick ratio of 0.76 and a debt-to-equity ratio of 5.53. The firm has a market capitalization of $3.44 billion, a PE ratio of 19.66, a P/E/G ratio of 1.82 and a beta of 1.88. The business has a fifty day moving average price of $31.41 and a two-hundred day moving average price of $29.21.
Cinemark (NYSE:CNK - Get Free Report) last issued its quarterly earnings results on Friday, May 2nd. The company reported ($0.32) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.32). Cinemark had a return on equity of 51.68% and a net margin of 8.17%. The firm had revenue of $540.70 million for the quarter, compared to analyst estimates of $604.62 million. During the same period in the previous year, the company posted $0.19 earnings per share. The company's quarterly revenue was down 6.6% compared to the same quarter last year. On average, research analysts predict that Cinemark will post 1.93 EPS for the current fiscal year.
Cinemark Cuts Dividend
The firm also recently declared a quarterly dividend, which was paid on Thursday, June 12th. Investors of record on Thursday, May 29th were given a dividend of $0.08 per share. The ex-dividend date of this dividend was Thursday, May 29th. This represents a $0.32 dividend on an annualized basis and a yield of 1.07%. Cinemark's dividend payout ratio (DPR) is presently 21.05%.
Insider Buying and Selling
In related news, EVP Melissa Thomas sold 7,200 shares of the stock in a transaction that occurred on Thursday, May 15th. The stock was sold at an average price of $31.43, for a total transaction of $226,296.00. Following the sale, the executive vice president directly owned 210,968 shares in the company, valued at $6,630,724.24. This represents a 3.30% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Wanda Marie Gierhart sold 52,524 shares of the stock in a transaction that occurred on Friday, June 13th. The stock was sold at an average price of $31.85, for a total value of $1,672,889.40. Following the sale, the insider owned 94,890 shares in the company, valued at approximately $3,022,246.50. This trade represents a 35.63% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 84,724 shares of company stock worth $2,724,435 in the last three months. Insiders own 2.10% of the company's stock.
Institutional Inflows and Outflows
A number of hedge funds have recently bought and sold shares of CNK. Raymond James Financial Inc. bought a new position in Cinemark in the 4th quarter valued at $1,494,000. Amundi bought a new position in Cinemark in the 4th quarter valued at $5,985,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in Cinemark by 23.7% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 27,978 shares of the company's stock valued at $867,000 after buying an additional 5,365 shares during the last quarter. HighTower Advisors LLC bought a new position in Cinemark in the 4th quarter valued at $224,000. Finally, Swiss National Bank boosted its position in Cinemark by 0.7% in the 4th quarter. Swiss National Bank now owns 216,600 shares of the company's stock valued at $6,710,000 after buying an additional 1,600 shares during the last quarter.
About Cinemark
(
Get Free Report)
Cinemark Holdings, Inc, together with its subsidiaries, engages in the motion picture exhibition business. As of February 16, 2024, it operated 501 theatres with 5,719 screens in 42 states and 13 countries in South and Central America. Cinemark Holdings, Inc was founded in 1984 and is headquartered in Plano, Texas.
Read More

Before you consider Cinemark, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cinemark wasn't on the list.
While Cinemark currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.